Multifocal ERG defects associated with insufficient long-term glycemic control in adolescents with type 1 diabetes
- PMID: 20484588
- PMCID: PMC3880359
- DOI: 10.1167/iovs.10-5200
Multifocal ERG defects associated with insufficient long-term glycemic control in adolescents with type 1 diabetes
Abstract
Purpose: To investigate the relationship between long-term glycemic control and localized neuroretinal function in adolescents with type 1 diabetes (T1D) without diabetic retinopathy (DR).
Methods: Standard (103 hexagons) and slow-flash (61 hexagons) multifocal ERGs (standard mfERG and sf mfERG) were recorded in 48 patients and 45 control subjects. Hexagons with delayed responses were identified as abnormal. Negative binomial regression analysis was conducted with the number of abnormal hexagons as the outcome variable. Glycated hemoglobin (HbA(1c)) levels, time since diagnosis of T1D, age at diagnosis of T1D, age at testing, and sex were the covariates. Another model replacing HbA(1c) closest to the date of testing with a 1-year average was also generated.
Results: There were more abnormal hexagons for mfOPs in patients than in control subjects (P = 0.005). There was no significant difference in the mean number of abnormal hexagons for standard mfERG responses between patients and control subjects (P = 0.11). Negative binomial regression analysis for the standard mfERG data demonstrated that a 1-unit increase in HbA(1c) was associated with an 80% increase in the number of abnormal hexagons (P = 0.002), when controlling for age at testing. Analysis using the 1-year HbA(1c) averages did not result in significant findings.
Conclusions: Poor long-term glycemic control is associated with an increase in areas of localized neuroretinal dysfunction in adolescents with T1D and no clinically visible DR. Stricter glucose control during the early stages of the disease may prevent neuroretinal dysfunction in this cohort.
Figures


Similar articles
-
Association between local neuroretinal function and control of adolescent type 1 diabetes.Invest Ophthalmol Vis Sci. 2012 Oct 9;53(11):7071-6. doi: 10.1167/iovs.12-10570. Invest Ophthalmol Vis Sci. 2012. PMID: 22977133 Free PMC article.
-
Blue flash ERG PhNR changes associated with poor long-term glycemic control in adolescents with type 1 diabetes.Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):741-8. doi: 10.1167/iovs.11-8263. Invest Ophthalmol Vis Sci. 2012. PMID: 22222270 Free PMC article.
-
Interocular symmetry of abnormal multifocal electroretinograms in adolescents with diabetes and no retinopathy.Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):316-21. doi: 10.1167/iovs.11-8825. Invest Ophthalmol Vis Sci. 2012. PMID: 22159016 Free PMC article.
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
-
Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements.Mayo Clin Proc. 2007 Feb;82(2):229-35; quiz 236. doi: 10.4065/82.2.229. Mayo Clin Proc. 2007. PMID: 17290732 Review.
Cited by
-
Association between local neuroretinal function and control of adolescent type 1 diabetes.Invest Ophthalmol Vis Sci. 2012 Oct 9;53(11):7071-6. doi: 10.1167/iovs.12-10570. Invest Ophthalmol Vis Sci. 2012. PMID: 22977133 Free PMC article.
-
Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.Curr Diab Rep. 2014;14(9):526. doi: 10.1007/s11892-014-0526-9. Curr Diab Rep. 2014. PMID: 25005120 Review.
-
AMPLITUDE LOSS OF THE HIGH-FREQUENCY FLICKER ELECTRORETINOGRAM IN EARLY DIABETIC RETINOPATHY.Retina. 2019 Oct;39(10):2032-2039. doi: 10.1097/IAE.0000000000002262. Retina. 2019. PMID: 30024576 Free PMC article.
-
Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy.Mol Vis. 2012;18:830-7. Epub 2012 Apr 4. Mol Vis. 2012. PMID: 22511846 Free PMC article.
-
Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study.Acta Diabetol. 2023 Jun;60(6):837-844. doi: 10.1007/s00592-023-02076-1. Epub 2023 Mar 23. Acta Diabetol. 2023. PMID: 36959506
References
-
- Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520–526. - PubMed
-
- Lecaire T, Palta M, Zhang H, Allen C, Klein R, D’Alessio D. Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4–14 years of type 1 diabetes: The Wisconsin Diabetes Registry Study. Am J Epidemiol. 2006;164:143–150. - PubMed
-
- International Diabetes Federation. United for Diabetes Campaign: Key Messages. Brussels, Belgium: 2007.
-
- Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786–806. - PubMed
-
- Juen S, Kieselbach GF. Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol. 1990;108:372–375. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous